Worth reading
72In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
4160000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise of stock acquisition rights with provisions for adjustment to the exercise price (monthly exercise status)
発行・処分する株式数
Shares delivered during the month: 4,160,000 new shares; 0 treasury shares transferred
Amount of funds to be raised
Aggregate exercise amount: ¥218.736 million; estimated net proceeds: Not disclosed
Existing Shares and Increase
+9.99%Rate of increase
45,778,119 shares49,938,119Shares
9.99% (4,160,000 shares delivered across all series / 41,618,119 listed shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥51.3, ¥53.1, ¥60.3, ¥59.4 and ¥55.8. Details of the exercise price adjustment clause and the adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total number issued: Not disclosed (the 41,600 Stock Acquisition Rights exercised during the month represented 15.94% of the total number issued); unexercised balance: 219,400 at the end of the preceding month and 177,800 as of the current date (representing 17,780,000 shares)
Procedures under the Corporate Code of Conduct
Report on compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments
Most recent equity financing
Timing 6 July 2026 / Type Issuance of the 20th Stock Acquisition Rights (with an exercise price adjustment clause) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of stock acquisition rights with provisions for adjustment to the exercise price (monthly exercise status) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 4,160,000 new shares; 0 treasury shares transferred |
| Amount of funds to be raised | Aggregate exercise amount: ¥218.736 million; estimated net proceeds: Not disclosed |
| Dilution Rate | 9.99% (4,160,000 shares delivered across all series / 41,618,119 listed shares outstanding as of the payment date for the issuance) |
| Total number of issued shares | 45,778,119 shares (as of the end of the month preceding the month under review) → 49,938,119 shares (the total shares issued as of the end of the preceding month plus the shares delivered during the month under review) |
| Exercise price | ¥51.3, ¥53.1, ¥60.3, ¥59.4 and ¥55.8. Details of the exercise price adjustment clause and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: Not disclosed (the 41,600 Stock Acquisition Rights exercised during the month represented 15.94% of the total number issued); unexercised balance: 219,400 at the end of the preceding month and 177,800 as of the current date (representing 17,780,000 shares) |
| Procedures under the Corporate Code of Conduct | Report on compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments |
| Most recent equity financing | Timing 6 July 2026 / Type Issuance of the 20th Stock Acquisition Rights (with an exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 20th Stock Acquisition Rights in August 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.